Neurometrix, Inc. operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Neurometrix with three other
companies in this sector in the United States:
Sonoma Pharmaceuticals Inc
sales of $16.66 million
of which 100%
was Drugs & Devices),
Repro-Med Systems, Inc.
Apyx Medical Corp
of which 78%
was Advance Energy).
During the year ended December of 2018, sales at
Neurometrix were $16.09 million.
decrease of 5.9%
versus 2017, when the company's sales were $17.09 million.